STONY BROOK, NY --(Marketwired - September 10, 2015) - Applied DNA Sciences, Inc. (
This agreement follows many months of partnership working between APDN, MSS Professional and Smoke & Screen Security Solutions (SmokeCloak Distributor for North America) to ensure the product is customer-friendly and provides forensic evidence to the high standards required by courts of law.
The unique SmokeCloak DNA security fog system, when deployed in pharmacies, banks, and other commercial/retail locations, works to protect staff, customers and assets. A thick and disorienting fog wards off offenders and deposits a unique, location-specific DNA marker on skin, clothing and stolen items. The combination of fog and DNA technologies has proven to be a deterrent to criminals; people and property are safer.
"This agreement provides MSS Professional A/S a significant unique selling point and tremendous benefits for our clients. Our Smoke systems serve to prevent criminals from stealing items as they cannot steal what they cannot see. The addition of SigNature DNA, which is mixed with the fog, enables law enforcement agencies to forensically link criminals and goods to a crime scene as each SmokeCloak unit will feature a unique DNA code. It is our expectation that SmokeCloak, together with APDN's DNA will prevent thousands of burglaries and robberies throughout the world," said Nick Bigler, CEO of MSS Professional A/S.
"We are delighted to continue to work with our partner MSS Professional A/S and their distributors. We believe that together we provide a unique winning combination of the leading fogging system and forensic SigNature DNA product, the latter of which has already helped to convict over 100 criminals," said Dr. James A Hayward, President and CEO of Applied DNA Sciences. "As is typical of our applications -- from protection against metal theft, to prevention of counterfeiting in electronics and textiles -- SmokeCloak DNA stands alone. It was created in collaboration with the law-enforcement community and we are proud that SmokeCloak DNA can make the world a safer place."
SmokeCloak DNA received a Popular Science "Best of What's New 2014" Award in the Security category, and has been featured on Discovery Channel Canada, WABC-TV, Bloomberg BusinessWeek, and other media outlets.
About Applied DNA Sciences We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature ® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopiable products such as DNAnet ® , our anti-theft product, SigNature ® T and fiberTyping ® , targeted toward textiles, and digitalDNA ® , providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Applied DNA Sciences common stock is listed on NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.
Forward Looking Statements The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11, 2015 and August 10, 2015, which are available at www.sec.gov . APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Investor contact: Debbie Bailey 631-240-8817 Email contact Media contact: Susan Forman Dian Griesel Int'l. 212-825-3210 Email contact Program contact: Tony Benson +44 7552 429341 Email contact web: Email contact twitter: @APDN
